Check out Profluent in STAT’s list of 7 companies to watch in AI protein design by Brittany Trang 👀 https://lnkd.in/er_54XzE
Profluent
Biotechnology Research
Emeryville, CA 5,802 followers
Decoding the language of life with AI
About us
Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Emeryville, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. To learn more about our mission to decode the language of life with AI, visit profluent.bio.
- Website
-
https://profluent.bio/
External link for Profluent
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Emeryville, CA
- Type
- Privately Held
- Founded
- 2022
- Specialties
- artificial intelligence, machine learning, biotech, and gene editing
Locations
-
Primary
Get directions
Emeryville, CA, US
Employees at Profluent
Updates
-
Tomorrow is the Genetic Engineering & Biotechnology News State of AI in Drug Discovery virtual event! Our CEO Ali Madani will be part of a panel discussing foundational models to read and write biology. Make sure to catch this exciting - and timely - session. 📅 Wednesday, October 30, 2024 🕚 2:30 PM ET / 11:30 AM PT 📍 Virtual, Main Stage Session Don’t forget to register here: bit.ly/StateAIDrug24
-
-
Check out this conversation with our ML Scientist Aadyot Bhatnagar on the Software Engineering Daily podcast! If this inspires you, we’re expanding our team to tackle the next set of moonshots. Join us 👉 https://lnkd.in/dQHv5d64
Aadyot Bhatnagar is an ML Scientist at Profluent and previously worked at Salesforce. He joins the show with Sean Falconer to talk about Profluent’s OpenCRISPR-1. Listen here: https://lnkd.in/gZurTNH8
Engineering an Open Source CRISPR with Aadyot Bhatnagar - Software Engineering Daily
softwareengineeringdaily.com
-
Who doesn’t love internships in proteinML research and open science? Check out the recent work by Profluent intern and Caltech PhD candidate, Jason Yang. Jason explored the adaptation of language models for conditional generation of enzymes with desired functions and taxonomies– with exciting results in extrapolation from what was seen in training! Profluent loves open science, so we’ve fully open-sourced the method, proCALM, for research and commercial use. Check it out for yourself: 🔗 Paper: https://lnkd.in/du4vNzNb 🔗 Code: https://lnkd.in/ddwhniE4
-
-
Don’t miss our VP and Head of Gene Editing Peter Cameron as one of the invited speakers at the upcoming AIChE - American Institute of Chemical Engineers 7th International Conference on CRISPR Technologies. 📣 Design of highly functional genome editors by modeling the universe of CRISPR-Cas sequences 📅 Wednesday, October 16, 2024 🕚 10:30 - 10:55 AM PT 📍 San Diego, CA #CRISPR2024
-
-
Exciting to see The Nobel Prize recognize how #AI is transforming science. The field is developing rapidly and the time to shape what it will mean for society - especially human health - is now. #NobelPrize
-
-
Attending the Alliance for Regenerative Medicine Cell and Gene Meeting on the Mesa next week? Meet with our CBO Hilary Eaton, PhD to explore how we can build together. #CGMesa24 #cellandgenetherapy
-
-
Reagent drop 🎤 After debuting OpenCRISPR-1, the world’s first AI-created and open-source gene editor, we’re thrilled to share that the tools detailed in our bioRxiv preprint have been added to the Addgene repository. 🧬 Access the plasmids here: https://lnkd.in/eRfvq4Fz Read more about OpenCRISPR-1: 🔗 Paper: https://lnkd.in/esbdquHt 🔗 Blog: https://lnkd.in/gGs-Qgt7 #GeneEditing #GeneticMedicines #OpenSourceScience #ReagentDrop
-
-
Our CBO Hilary Eaton, PhD joined Matthew Pillar on the Business of Biotech podcast to talk about her exposure to CRISPR when the technology was still in its infancy, her drive to directly impact patient lives - as well as her own personal connection to rare disease, and how Profluent’s use of AI is flipping the drug development paradigm upside down. Check it out: https://lnkd.in/eWcsX5ED
An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.
https://www.youtube.com/
-
Catch our CEO Ali Madani during a panel discussion on foundational models in biology as part of The State of AI in Drug Discovery virtual summit on Oct. 30, organized by Fay Lin, PhD and Genetic Engineering & Biotechnology News. Register for free 👉 https://lnkd.in/gnGGAK_r
I'm thrilled to be leading GEN's (Genetic Engineering & Biotechnology News) inaugural virtual summit, "The State of AI in Drug Discovery", streaming on October 30th! We have an INCREDIBLE line-up of founders, executives, and researchers to discuss the latest advances, challenges and concerns regarding the deployment of #AI in biotech, with particular emphasis on disrupting the drug discovery process. Check it out ⬇️ ◾️ A keynote fireside chat with Najat Khan, PhD (Recursion) on growing the AI in drug discovery industry ◾️ A keynote presentation with protein design expert David Baker (Institute for Protein Design, University of Washington) ◾️ From computational platforms to protein therapeutics with Ava Amini (Microsoft Research), Gevorg Grigoryan (Generate:Biomedicines), and Karen Akinsanya (Schrödinger) ◾️ Foundational models to read and write the language of biology with Ali Madani (Profluent), Brian Hie (Stanford University), and Alex Rives (EvolutionaryScale). ◾️ Key considerations for AI-based small molecule drug discovery with Jen Nwankwo, Ph.D. (1910 Genetics), Jacob Berlin, PhD (Terray Therapeutics), Philip Tagari (insitro), and Alex Zhavoronkov (Insilico Medicine) ◾️ AI in drug discovery’s evolving business landscape with Simon Barnett (Dimension), Sabrina Yang (Empress Therapeutics/Flagship Pioneering), and Colin Hill (Aitia) Registration is FREE! Get your spot today! ➡️ https://lnkd.in/gnGGAK_r
-